Brief: Cleveland Clinic Transfers Breast Cancer Vaccine IND to Anixa
15/12/2025 15:51
Dec 15 (Reuters) - Anixa Biosciences Inc ANIX.O: ANIXA BIOSCIENCES ANNOUNCES TRANSFER OF IND FOR BREAST CANCER VACCINE FROM CLEVELAND CLINIC ANIXA BIOSCIENCES INC - TO ADVANCE BREAST CANCER VACCINE INTO PHASE 2 TRIAL Source text: ID:nPn4Gz6K2a Further company coverage: ANIX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anixa Biosciences
See all newsBrief: Anixa Biosciences Announces First Case Of Stable Disease For Three Months In Ovarian Cancer Car-T Clinical Trial
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Anixa Biosciences Inc reports results for the quarter ended July 31 - Earnings Summary
Anixa Biosciences Inc expected to post a loss of 9 cents a share - Earnings Preview
Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine